Seeking Alpha

Diversify

Diversify
Send Message
View as an RSS Feed
View Diversify's Comments BY TICKER:
Latest  |  Highest rated
  • Mannkind: Denied Yet Again [View article]
    Generex on-going treatment IND for Oral-lyn would seem to indicate the FDA's willingness to accept a buccal insulin spray. The ball is in Generex' court to complete the overdue Phase III and present a compelling case to the FDA for approval.
    Jan 20 03:27 PM | 2 Likes Like |Link to Comment
  • News Next Week for Generex May Reduce Need for Reverse Split [View article]
    "Generex's (GNBR) buccal spray does not develop autoimmunity versus other methods of intake including needle injection"

    This strikes me as a very significant finding, but one I have heard next to nothing about. I hope you can enlighten us on the autoimmunity issue in future commentary.
    Sep 16 06:51 PM | Likes Like |Link to Comment
  • The Great ‘Deflation Lie’ [View article]
    If you'll recall, Hoover and FDR increased taxes massively, which contributed to deflation, because it reduced the amount of money available to produce goods and services. There was also a significant reduction in the amount of credit available to the consumer. Both of these components contribute to deflation and that is what we are experiencing, but at a slower rate than the Great Depression.
    Aug 12 03:14 PM | Likes Like |Link to Comment
  • Generex and Its Insulin Spray: Just Hype? [View article]
    The Phase II results for OL are undeniable and the Treatment IND is a clear indication the Phase III results are also positive. Throw in a remarkable interim result on the AE37 Phase II and you have to conclude that this is a small but serious, innovative company that is succeeding against the odds. Now the question becomes: What is the motivation of people who clearly know better and still publish misinformation? I conclude that there is some seriously scared competition that are doing what they can to waylay the company through online sell-outs.
    Apr 7 01:37 PM | 6 Likes Like |Link to Comment
  • In Support of Generex from TheStreet [View instapost]
    Generex is still a story in progress, but it is ludicrous to portray this company as a "total bust" as Feuerstein did. Until the Phase III results are presented, the jury must remain out, but given the FDA's actions so far, I have to lean in Oral-lyn's favor.
    Mar 22 11:48 AM | 1 Like Like |Link to Comment
  • A N.I.C.E. Development for Generex Oral-lyn in the U.K. [View article]
    Generex received a referral from NICE in Feb 2010, so they have advanced to the next step. They do not have an estimate on when the process will complete, but the end of the year is a reasonable expectation. It is listed under buccal insulin on the NICE website.
    Feb 6 10:47 AM | Likes Like |Link to Comment
  • Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage [View article]
    Oral-lyn is a real manufactured product now selling in a real country. The insulin delivered is standard insulin, the innovation is buccal absorption. Given the recent failure of lung-delivered freeze-dried insulin, it appears Generex is poised to accomplish what the major drug companies couldn't do. Good luck to Generex and I hope diabetics, especially children, soon have a needle-less way to deliver insulin safely at meal-time.
    Apr 12 05:23 PM | 1 Like Like |Link to Comment
COMMENTS STATS
7 Comments
10 Likes